$0
President
2024
President at Scleroderma Clinical Trials Consortium Inc.
Fiscal year ended December 31, 2024. Published on January 25, 2026.
Total compensation
Robyn Therese Domsic-Degazio has been listed as an employee of Scleroderma Clinical Trials Consortium Inc. in Form 990 filings since fiscal year 2023.